Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SNDK vs GSK✓SelectedUSD · GSKSNDK vs GSK performance historyLatest closeAs of-2.71%11/19
Stock and ETF performance explorer

SNDK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-45.8%
GSK return
-4.8%
Excess return
-41.0%
Maximum drawdown
-67.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.7%-1.6%-1.1%-4.6%
7D-19.4%-4.7%-14.7%-24.2%
30D-44.7%-4.7%-40.0%-47.2%
3M-51.9%-8.8%-43.1%-56.8%
All-45.8%-4.8%-41.0%-46.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling